Hanover Advisors’s Globus Medical GMED Stock Holding History

Hanover Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$441K	Hold	5,580	–	–	0.16%	77
2026 Q1	$481K	Hold	5,580	–	–	0.2%	68
2025 Q4	$487K	Hold	5,580	–	–	0.19%	63
2025 Q3	$320K	Hold	5,580	–	–	0.12%	80
2025 Q2	$329K	Hold	5,580	–	–	0.13%	69
2025 Q1	$408K	Hold	5,580	–	–	0.18%	58
2024 Q4	$462K	Hold	5,580	–	–	0.19%	51
2024 Q3	$399K	Hold	5,580	–	–	0.17%	59
2024 Q2	$382K	Hold	5,580	–	–	0.17%	60
2024 Q1	$299K	Hold	5,580	–	–	0.13%	77
2023 Q4	$297K	Buy	+5,580	New	+$272K	0.15%	72

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Hanover Advisors's GMED Position: Q2 2026 in Review

Hanover Advisors held its Globus Medical (GMED) position steady in Q2 2026 at 5,580 shares worth $441K. The position accounts for 0.16% of the portfolio, ranked #77.

Hanover Advisors first reported a position in GMED in Q4 2023 and has held it in 11 quarters since. The position peaked at $487K in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Hanover Advisors held 5,580 shares of Globus Medical worth $441K as of Q2 2026.
Hanover Advisors left its Globus Medical share count unchanged in Q2 2026.
Globus Medical made up 0.16% of Hanover Advisors's portfolio in Q2 2026, its #77 holding.
Hanover Advisors first reported a position in Globus Medical in Q4 2023 and has held it in 11 quarters since.
Hanover Advisors's Globus Medical position peaked at $487K in Q4 2025.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Hanover Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.